Zobrazeno 1 - 10 of 30 pro vyhledávání: '"Michelle T Martin"'
1
Akademický článek
Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program
Autor: Sun A Choi, Kandavadivu Umashankar, Anjana Maheswaran, Michelle T Martin, Jean Lee, Matt Odishoo, Janet Y Lin, Daniel R Touchette
Publikováno v: BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background In the United States (US), hepatitis C virus (HCV) screening is not covered by payers in settings outside of primary care. A non-traditional, emergency department (ED)-based HCV screening program can be cost-effective and identify
Externí odkaz: https://doaj.org/article/31ca22f582de4eb6854685f5cab4c792
Zobrazit plný text záznamu
2
Akademický článek
Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy
Autor: Nadia A. Nabulsi, Michelle T. Martin, Lisa K. Sharp, David E. Koren, Robyn Teply, Autumn Zuckerman, Todd A. Lee
Publikováno v: Frontiers in Pharmacology, Vol 11 (2020)
Introduction: Hepatitis C virus (HCV), the leading cause of advanced liver disease, has enormous economic burden. Identification of patients at risk of treatment failure could lead to interventions that improve cure rates.Objectives: Our goal was to
Externí odkaz: https://doaj.org/article/fd36e588f2e948c1a6637cccc5a6466f
Zobrazit plný text záznamu
4
High Real-World Sustained Virologic Response Rate with Glecaprevir/Pibrentasvir at a Racially Diverse Urban Academic Medical Center
Autor: Michelle T. Martin, Nicole Waring, Ammara Naveed
Publikováno v: Gut and Liver
Background/Aims Glecaprevir/pibrentasvir (G/P) is a combination of direct-acting antiviral agents that is an approved treatment for chronic infections by all six hepatitis C virus (HCV) genotypes. However, there are limited data on the effect of G/P
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::891244623ade82d0bd88a8e9416becf0
https://doi.org/10.5009/gnl210499
Zobrazit plný text záznamu
9
Practical considerations when treating chronic hepatitis E in solid organ transplant recipients
Autor: Wadih Chacra, Sean Koppe, Lisa Landers, Adam E. Mikolajczyk, Ammara Naveed, Christine Chan, David K. Choi, Michelle T. Martin
Publikováno v: International Journal of Clinical Pharmacy. 43:753-755
Hepatitis E virus (HEV) can lead to chronic infections in immunosuppressed patients. The use of ribavirin to treat chronic HEV has been well-established in case reports and guidelines. However, practical approaches to the use of this antiviral treatm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cce2afa0a349ec7a2074ae8032ca8e7
https://doi.org/10.1007/s11096-020-01195-x
Zobrazit plný text záznamu
10
Sustained Virologic Response Rates Before and After Removal of Sobriety Restriction for Hepatitis C Virus Treatment Access
Autor: Michelle T. Martin, Nicole Waring, Jasmine Forrest, Jonathan L. Nazari, Abdullah I. Abdelaziz, Todd A. Lee
Publikováno v: Public Health Reports. :003335492210993
Objectives: Until November 1, 2018, Illinois Medicaid restricted coverage of hepatitis C virus (HCV) medication to patients with sobriety from alcohol and illicit substances for ≥12 months. This policy limited treatment access for patients with a h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b293f7d9cb611745aa823e16505c5638
https://doi.org/10.1177/00333549221099323
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje